Nov 21 (Reuters) - Essa Pharma Inc EPI.TO :
* ESSA Pharma Inc says will initially draw down US$8 million and has a conditional option to receive an additional US$2 million
* ESSA Pharma Inc says proceeds from term loans will be used for company's future working capital needs
* ESSA Pharma Inc says term loans bear an interest rate of Wall Street Journal prime rate plus 3.0 pct annually and will mature on September 1, 2020
* ESSA secures US$10 million term loan from Silicon Valley Bank Source text for Eikon: ID:nPnF8fsWa Further company coverage: EPI.TO